Showing results (321-330 of 450) with videos related to
Sort By:
Pageof 45
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|March 1, 1994
Epstein-Barr virus genomes in undifferentiated and squamous cell nasopharyngeal carcinomas in Italian patientsG Della Torre, S Pilotti, R Donghi, et al.Oncogene|December 11, 1997
The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and NckR Bocciardi, B Mograbi, B Pasini, et al.Human Mutation|March 27, 1999
Screening for mutations of the APC gene in 66 Italian familial adenomatous polyposis patients: evidence for phenotypic differences in cases with and without identified mutationM Giarola, L Stagi, S Presciuttini, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|June 15, 2001
Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumorsS Birindelli, F Perrone, M Oggionni, et al.Cancer Research|January 15, 1993
Chromosome mapping of murine susceptibility loci to liver carcinogenesisM Gariboldi, G Manenti, F Canzian, et al.British Journal of Cancer|February 12, 1998
Detection of TP53 mutation, loss of heterozygosity and DNA content in fine-needle aspirates of breast carcinomaC Lavarino, V Corletto, A Mezzelani, et al.Oncogene Research|January 1, 1988
Modulation of the human Harvey-ras oncogene expression by DNA methylationM G Borrello, M A Pierotti, R Donghi, et al.Melanoma Research|November 1, 1992
Treatment of recurrent in transit metastases from cutaneous melanoma by isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine activated killer cells. A pilot studyF Belli, F Arienti, L Rivoltini, et al.Cancer Research|January 4, 1998
Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursorsR Mortarini, A Anichini, M Di Nicola, et al.Cancer Research|June 11, 1998
Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma/melanocyte epitope MART1(27-35)D J Loftus, P Squarcina, M B Nielsen, et al.Pageof 45